Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
Inappropriate schedule of product administration; No adverse event; Information has been received from Business Partner/CRO on 18-Feb-2025. This spontaneous report was received from a/an Consumer or other non health professional and refers to a(n) Child patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (indication, expiration date, and lot # were not reported). On an unknown date, the patient experienced Inappropriate schedule of product administration. On an unknown date, the patient experienced No adverse event. At the reporting time, the outcome of Inappropriate schedule of product administration and No adverse event was unknown.
Sterile Diluent